Unilever Consumer Care has staged a strong comeback in the third quarter of 2025, thanks to a sharp rise in Horlicks sales and easing inflation across Bangladesh. The company recorded a 26 percent year-on-year revenue growth to reach Tk 1 billion between July and September, marking its most notable quarterly recovery in recent times.
According to its latest financial report, Horlicks sales surged 24 percent to Tk 961 million, contributing more than 90 percent of total revenue. As inflation fell below 9 percent for the first time in over two years, consumers began returning to smaller, more affordable packs of the popular health drink. In contrast, glucose powder sales dropped 10 percent to Tk 47 million during the same quarter.
Read More: Nestlé Bangladesh Brings Free Healthcare to 500 People in Sreepur
The rebound in Horlicks demand, coupled with improved operational efficiency and focused marketing campaigns, helped Unilever Consumer Care achieve a 55 percent year-on-year profit growth, reaching Tk 247 million for the quarter. Earnings per share (EPS) rose to Tk 12.80, up from Tk 8.26 in the same period last year.
Chairman Masud Khan said the company’s focus on affordability and relevance, particularly among students and middle-income consumers, played a key role in its recovery. After a difficult 2024 when rising inflation turned Horlicks into a discretionary item, the brand has regained its place in daily household consumption.
For the first nine months of 2025, the company’s total profit climbed 10 percent to Tk 628 million, supported by a 39 percent increase in net finance income to Tk 232 million. It also benefited from a Tk 17.8 million gain due to royalty adjustments for technology and trademarks.
Read More: Prime Bank Profit Rises 27% to Tk 629 Crore in Q3 2025
Despite a 30 percent decline in annual profit in 2024 caused by high inflation and lower consumer spending, Unilever Consumer Care paid a 520 percent cash dividend, its highest in five years, as foreign exchange pressures eased.
Listed in 1976 as GlaxoSmithKline Bangladesh, the company was acquired by Unilever Group in 2020 for over Tk 20 billion and renamed Unilever Consumer Care, focusing on healthcare and nutrition products. Following the latest earnings announcement, its share price on the Dhaka Stock Exchange rose 1 percent to Tk 2,421.30, making it the fourth most-valued stock on the bourse.